Please assess the completion status of the following clinical trial:

Trial Title: Analgesia and Physiotherapy in Children With Cerebral Palsy (ANTALKINECP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cerebral palsy hemiplegic diplegic or tetraplegic spastic or not.~* Children who feel pain during the pre-screening physiotherapy session with a VAS score above 2.~* Aged 6 to 17 years of both gender.~* Ability to express his/her pain and to measure its intensity with VAS.~* Informed and signed (parents, investigator and child if possible).~Exclusion Criteria:~* Lack of physiotherapy.~* Analgesic treatment already available or stopped in the last month.~* Scheduled surgery procedure or botulinum toxin injection during the period of the assessment of pain (around 5 month)~* The last botulinum toxin injection in two months before the inclusion~* Child who feel pain with EVA score superior or equal to 4 at the time of the inclusion outside the sessions of physiotherapy~* Child unable to cooperate.~* Severe infection or instable vital functions.~* Hypersensitivity to ibuprofen or any of the constituents in the product.~* History of allergy or asthma triggered by taking ibuprofen or substances of near activity such as other NSAIDs and aspirin.~* Allergy to other component of treatment.~* History of upper gastrointestinal bleeding or perforation, related to previous NSAID therapy.~* Active gastrointestinal ulcer.~* Severe hepatic failure.~* Severe renal failure.~* Uncontrolled severe cardiac failure.~* Systemic Lupus Erythematosus.~* Regular intake of ibuprofen~Randomisation Criteria:~• Child who feel pain during the physiotherapy session with a mean VAS score above 3 during the screening phase.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Ibuprofen (Type: EXPERIMENTAL): Active ibuprofen
- Placebo (Type: PLACEBO_COMPARATOR): Placebo of ibuprofen

Based on this trial design, predict the completion outcome and termination type (if applicable).